REVOLUTIONIZING THE DIAGNOSIS OF

INFLAMMATORY
BOWEL DISEASES

We pioneer non-invasive stool tests, leveraging patient transcriptome & an AI-driven classifier, for advanced transcriptomics and precise diagnostics of inflammatory bowel diseases.

OUR MISSION

TRACELL'S PRECISION DIAGNOSIS

Non-Invasive Stool Testing for Accurate Detection and Characterization of Inflammation

Tracells' stool test utilizes RNA profiles from patients' intestinal cells, which are shed into the stool, for accurate IBD diagnosis.

The AI-driven analysis offers insights into inflammation severity, location, and probabilities to response to diverse therapies.

IBD DIAGNOSIS IS CHALLENGING

Current non-invasive blood and fecal tests lack specificity for IBD diagnosis and cannot pinpoint inflammation locations, necessitating invasive diagnostic procedures.

Achieving endoscopic remission, a key treatment goal for IBD, currently requires invasive methods like endoscopies and biopsies.

There is a pressing need for accurate non-invasive methods to diagnose IBD

ADVANCED BOWEL INFLAMMATION MAPPING

The Benefits of Inflammation Characterization via Stool Testing:

PERSONAL THERAPY

Capture colonoscope equivalent biometric data

CONVENIENCE

Home-based stool test, decreasing reliance on invasive procedures

PRECISION

~1000-gene analysis for highly accurate diagnosis

MONITORING

Non-invasive & budget-friendly, allowing for regular tracking in proactive disease management

PATENT

Utilizes licensed patented technology that increases signal over noise